Exploring opposing arguments in the call for randomized controlled trials to demonstrate benefit of Mohs micrographic surgery for cutaneous melanoma
Dermatology Online Journal · 2024
DOI: 10.5070/d330564424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Online Journal, 2024. Verfasst von Nahid Y Vidal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota, USA. Vidal.Nah…. Hauptthemen laut MEDLINE: Mohs Surgery, Melanoma, Skin Neoplasms, Randomized Controlled Trials as Topic.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota, USA. Vidal.Nahid@mayo.edu.
Zitieren
APA
Vidal, N. Y., O'Hern, K., Steen, A., Carley, S., & Ahn, J. W. (2024). Exploring opposing arguments in the call for randomized controlled trials to demonstrate benefit of Mohs micrographic surgery for cutaneous melanoma. Dermatology Online Journal. https://doi.org/10.5070/d330564424
Vancouver
Vidal NY, O'Hern K, Steen A, Carley S, Ahn JW. Exploring opposing arguments in the call for randomized controlled trials to demonstrate benefit of Mohs micrographic surgery for cutaneous melanoma. Dermatology Online Journal. 2024. doi:10.5070/d330564424
BibTeX
@article{Vidal2024,
author = {Vidal, Nahid Y and O'Hern, Keegan and Steen, Aaron and Carley, Sama and Ahn, Ji Won},
title = {Exploring opposing arguments in the call for randomized controlled trials to demonstrate benefit of Mohs micrographic surgery for cutaneous melanoma},
journal = {Dermatology Online Journal},
year = {2024},
doi = {10.5070/d330564424}
}
EUVIMED